Thrombotic microangiopathy in systemic lupus erythematosus: A cohort study in North Taiwan

Rheumatology

Volumn 50, Issue 4, 2011, Pages 768-775

  Chen, Ming Han ^a,b   Chen, Ming Huang ^a,b   Chen, Wei Sheng ^a,b   Chang, Peter Mu Hsin ^a,b   Lee, Hui Ting ^a,b   Lin, Hsiao Yi ^a,b   Huang, De Feng ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Infection; Plasma exchange; Systemic lupus erythematosus; Thrombotic microangiopathy

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; COHORT ANALYSIS; FEMALE; HUMAN; KIDNEY DYSFUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TAIWAN; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 79952812128     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq311     Document Type: Article

References (44)

1. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.
2. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006;354:1927-35.
3. Tsai HM. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am 2007;21:609-32, v.
4. Furlan M, Robles R, Galbusera M et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
5. Karmali M, Petric M, Lim C et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151:775-82.
6. Cleary TG. Cytotoxin-producing Escherichia coli and the hemolytic uremic syndrome. Pediatr Clin North Am 1988; 35:485-501.
7. Tsai HM. The molecular biology of thrombotic microangiopathy. Kidney Int 2006;70:16-23.
8. Kwok SK, Ju JH, Cho CS, Kim HY, Park SH. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study. Lupus 2009;18:16-21.
9. Letchumanan P, Ng HJ, Lee LH, Thumboo J. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology 2009;48:399-403.
10. Shah AA, Higgins JP, Chakravarty EF. Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties. Nat Clin Pract Rheumatol 2007;3: 357-62.
11. Cheung WY. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus-distinct entities or overlapping syndromes? Transfus Apher Sci 2006;34:263-6.
12. Hamasaki K, Mimura T, Kanda H et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review. Clin Rheumatol 2003;22:355-8.
13. Singh R, Saunders B, Scopelitis E. Pancreatitis leading to thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case report and review of literature. Lupus 2003;12:136-9.
14. Guvenc B, Unsal C, Gurkan E, Canataroglu A, Saritas B, Evran M. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report. Transfus Apher Sci 2004;31:17-20.
15. Zhang W, Shi H, Ren H et al. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study. Nephron Clin Pract 2009;112: c177-83.
16. Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H. A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review. Am J Nephrol 2002;22:576-80.
17. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiographic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 1994;24:165-72.
18. Azharuddin M, Bhatti MA. Hemolytic uremic syndrome with systemic lupus erythematosus. J Coll Physicians Surg Pak 2005;15:306-8.
19. Rabbani MA, Ahmad B, Mekan SF, Muzaffar S, Ali SS. Systemic lupus erythematosus presenting as hemolytic uremic syndrome: a case report. J Pak Med Assoc 2005; 55:84-7.
20. Dold S, Singh R, Sarwar H, Menon Y, Candia L, Espinoza LR. Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome. Arthritis Rheum 2005;53:982-5.
21. Jain R, Chartash E, Susin M, Furie R. Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 1994;24:173-82.
22. Vasoo S, Thumboo J, Fong KY. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs. Lupus 2002;11: 443-50.
23. Musio F, Bohen EM, Yuan CM, Welch PG. Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus. Semin Arthritis Rheum 1998;28:1-19.
24. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991;325:398-403.
25. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
26. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005;31:681-90.
27. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15: 241-50.
28. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;35:630-40.
29. Nikpour M, Urowitz MB, Ibanez D, Gladman DD. Frequency and determinants of flare and persistently active disease in systemic lupus erythematosus. Arthritis Rheum 2009;61:1152-8.
30. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005;365:417-30.
31. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
32. Vincent JL, Moreno R, Takala J et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
33. Allford SL, Hunt BJ, Rose P, Machin SJ. Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias. Br J Haematol 2003;120: 556-73.
34. Mannucci PM, Vanoli M, Forza I, Canciani MT, Scorza R. von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis). Haematologica 2003;88:914-8.
35. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005;38:473-85.
36. Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Systemic lupus erythematosus and infections: a retrospective study in Saudis. Lupus 2007;16:755-63.
37. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006;6: 823-35.
38. Sekigawa I, Kawasaki M, Ogasawara H et al. DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 2006;6:99-106.
39. Pollock KG, Young D, Beattie TJ, Todd WT. Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005. Epidemiol Infect 2008;136:115-21.
40. Douglas KW, Pollock KG, Young D, Catlow J, Green R. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a singleinstitution experience. J Clin Apher 2010;25:47-53.
41. Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-related morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol 2007;26:663-70.
42. Khalifa M, Kaabia N, Bahri F, Ben Jazia E, Bouajina E, Omezzine Letaief A. Infection in systemic lupus erythematosus. Med Mal Infect 2007;37:792-5.
43. Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin 2002;18:375-92.
44. Schneider M. Thrombotic microangiopathy (TTP and HUS): advances in differentiation and diagnosis. Clin Lab Sci 2007;20:216-20.